A phase II trial of TS-1/CDDP as neoadjuvant chemotherapy against resectable gastric cancer.
Phase of Trial: Phase II
Latest Information Update: 03 May 2017
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 01 May 2017 Status changed from recruiting to completed.
- 02 Jul 2014 New trial record